Yuvraj

Therapure Biopharma to Attend BioProcess International Conference & Exhibition

Therapure Biopharma is appearing at the upcoming BioProcess International Conference & Exhibition. The company can be found at booth number 818....

Daiichi Sankyo to buy Ambit Biosciences for $410m

Japan-based Daiichi Sankyo has signed an agreement to acquire US-based Ambit Biosciences, for about $410m. As part of the deal,...

Cipla Medpro to market Teva’s pharmaceutical products in South Africa

Cipla Medpro subsidiary Medpro Pharmaceutica has entered into an agreement with Teva Pharmaceuticals. As part of the deal, Medpro will exclusively...

GSK to acquire 25% stake in Aspen Japan

British drug maker GlaxoSmithKline (GSK) has signed an agreement with Aspen Global (AGI) to acquire interest in its newly established subsidiary ...

Boehringer brings Striverdi Respimat to market for COPD treatment in US

Boehringer Ingelheim Pharmaceuticals has introduced Striverdi Respimat (olodaterol) inhalation spray 5µg in the US market. Striverdi Respimat is indicated to...

Nabriva’s lefamulin receives FDA fast-track status to treat CABP and ABSSSI

Austria-based Nabriva Therapeutics has received qualified infectious disease product (QIDP) and fast-track status designation from the US Food and Drug Administration for...

Pharma ‘cannot deliver patient centricity’

Eyeforpharma, London, September 2014: Mary Baker, immediate past President of the European Brain Council, believes that pharma companies are focusing too...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read